News Center

As the COVID-19 pandemic reaches a critical stage in several countries around the world, we…

Is a company a societal microcosm? Today, a company cannot escape the debates that shake…

Ipsen, we are determined to show our commitment to patients with rare diseases including acromegaly,…

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Date:            Thursday, February 13, 2020 Time:            Conference call and webcast – 2:30pm CET / 8:30 EST…

John Chaddock, VP Interim Global Head Neuroscience Therapeutic Area, Site Head Ipsen Bioinnovation, Ipsen As…

Working with patients, for patients, underlines everything we do at Ipsen. Understanding their quality of…

Developing new and innovative treatments for patients is our mission here at Ipsen, and we…

Luxembourg (France), 19 December 2019 – As previously announced in a press release dated November…

Understanding the importance of conducting business with the highest ethical standards, we asked Dominique…

Ipsen has further bolstered its CSR commitment by adding social responsibility criteria to its new…

Bartek Bednarz, SVP Global Product and Portfolio Strategy, Ipsen November has become synonymous with Movember,…